Although there is no research available regarding their association with NK cells in these tumors, it can be assumed that certain CXCR2 ligands participate in an anticancer process that stimulates the immune response and the infiltration of the tumor by NK cells. This evidence concerns the gene CXCR2 and neoplasm.